Inogen Inc Common Stock (INGN)

About INGN

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a porta…

Sector

Health Care

Industry

Industrial Specialties

Employees

753

Website

www.inogen.com/

Fundamentals

1-day range

$5.46$5.63

Market cap

$181.67M

P/E (trailing)

—

P/E (forward)

-34.38

EPS (trailing)

$-0.92

Dividend yield

—

Beta

1.51

Avg. volume

267.3K

Forecasts

3 analyst ratings

Inogen Inc Common Stock Competitors

Chosen by industry and closest market cap.

• INGN

  Inogen Inc Common Stock

  $5.51

  ▼ 0.09%
  Market cap $181.67MP/E —
  $5.34$9.13
• BOOM

  DMC Global Inc. Common Stock

  $6.89

  ▼ 1.43%
  Market cap $148.51MP/E —
  $4.69$9.2
• CHPT

  ChargePoint Holdings Inc. Common Stock

  $5.57

  ▼ 4.55%
  Market cap $142.95MP/E —
  $4.44$12.61
• YDDL

  One and One Green Technologies. Inc Class A Ordinary Shares

  $1.68

  ▼ 1.18%
  Market cap $107.81MP/E 6.41
  $1.65$16.23
• HDSN

  Hudson Technologies Inc. Common Stock

  $5.42

  ▼ 1.09%
  Market cap $262.09MP/E 16.80
  $4.64$10.52
• SPAI

  Safe Pro Group Inc. Common Stock

  $4.68

  ▼ 6.96%
  Market cap $83.09MP/E —
  $3.23$9.16
• NTIC

  Northern Technologies International Corporation Common Stock

  $8

  ▼ 0.87%
  Market cap $79.87MP/E —
  $7.25$10.03

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Top 3 Health Care Stocks That Could Blast Off This Month
  benzinga · 8/19/2026
• Top 3 Health Care Stocks That Could Blast Off This Month
  Benzinga · 8/19/2026
• Inogen, Inc. (INGN) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/7/2026
• Inogen, Inc. 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/6/2026
• Inogen (NASDAQ:INGN) Falls as Revenue Misses and Full-Year Guidance Trails Estimates
  ChartMill · 8/6/2026
• Inogen Lowers FY2026 Sales Guidance from $366.000M-$373.000M to $355.000M-$361.000M vs $369.267M Est
  Benzinga · 8/6/2026
• Inogen Sees Q3 Sales $92.400M vs $98.967M Est
  Benzinga · 8/6/2026
• Inogen Q2 Sales $95.084M Miss $95.233M Estimate
  Benzinga · 8/6/2026

• Reding Andrew P. · July 6, 2026 · Grant

  130.0K
• Boyer Jennifer M. Yi · July 1, 2026 · Sale

  10.9K @ $6.6
• Mira Kirti Sahney · June 5, 2026 · Grant

  28.1K
• Vafa Jamali · June 5, 2026 · Grant

  28.1K
• Mary Kay Ladone · June 5, 2026 · Grant

  28.1K
• Glenn S. Boehnlein · June 5, 2026 · Grant

  28.1K
• Heather D. Rider · June 5, 2026 · Grant

  28.1K
• Elizabeth Mora · June 5, 2026 · Grant

  28.1K
• Kevin M. King · June 5, 2026 · Grant

  28.1K
• Boyer Jennifer M. Yi · May 29, 2026 · Sale

  10.8K @ $6.53
• Richardson Jason Andrew · April 6, 2026 · Grant

  100.0K
• Mary E. Wright · March 1, 2026 · Option Exercise

  3.0K
• Mary E. Wright · March 1, 2026 · Option Exercise

  2.8K
• Mary E. Wright · March 1, 2026 · Option Exercise

  1.8K
• Mary E. Wright · March 1, 2026 · Tax Withholding

  1.2K @ $6.1

Institutional Ownership

March 31, 2026

Total shares held

17.83M

Total value held

$98.92M

Institutional holders

120